Post

Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab

Biopharma giant AbbVie has announced it intends to terminate its cancer drug deal with I-Mab, the creators of lemzoparlimab. The …

AstraZeneca and IKN to launch AI X-ray technology for early lung screening

AstraZeneca has collaborated with Malaysia-based Institut Kanser Negara (IKN) to introduce artificial intelligence (AI) X-ray technology for lung screening. As part …

Vibrant Wellness introduces new Toxin Genetics Test

Vibrant Wellness has expanded its functional lab test portfolio with the launch of the new Toxin Genetics Test for personalised …

Biomerics completes Brooklyn Park facility expansion in US

Medical device contract manufacturer Biomerics has completed a 100,000ft² expansion of its operations in Brooklyn Park, Minnesota, US. With the expansion, …

US Medical Innovations to launch new AI surgical system

US Medical Innovations (USMI) and the Jerome Canady Research Institute for Advanced and Biological Technological Sciences (JCRI-ABTS) have announced the …